Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
H.B. Fuller Company (NYSE: FUL) has reportedly submitted a 285 pence-per-share cash offer to acquire Advanced Medical Solutions Group (LON: AMSU), intensifying takeover interest in the UK-based medical technology company. The proposed acquisition highlights growing consolidation in the healthcare and medical device sector during 2026.
The Minnesota-based adhesives manufacturer is currently conducting due diligence and holding discussions with Advanced Medical Solutions after making an unsolicited proposal on April 30, 2026. Under UK takeover regulations, H.B. Fuller must announce a firm intention to proceed with a formal bid or withdraw its interest by June 18, 2026.
According to reports, Goldman Sachs and Perella Weinberg Partners are advising H.B. Fuller on the potential transaction, while Ashurst LLP serves as legal counsel. Advanced Medical Solutions is being advised by Evercore Partners International and Investec Bank.
The possible acquisition comes shortly after private equity firm TA Associates ended its pursuit of Advanced Medical Solutions earlier this month. TA Associates had reportedly considered an offer near 280 pence per share, valuing the company at around £600 million. Before that, Montagu Private Equity also explored a potential bid but did not move forward.
Analysts believe Advanced Medical Solutions has become increasingly attractive following its 2024 acquisition of Peters Surgical, a France-based surgical products company. The deal significantly expanded AMSU’s manufacturing and sales capabilities across Europe and Asia.
The integration of Peters Surgical helped boost Advanced Medical Solutions’ 2025 revenue by 29% to £228.9 million, while adjusted EBITDA climbed 24% to £49.9 million. Industry experts suggest these stronger financial results and potential cost synergies could motivate strategic buyers like H.B. Fuller to pursue a takeover.
Despite ongoing negotiations, both companies emphasized that there is no certainty a final agreement will be reached. Investors continue monitoring developments closely as the June deadline approaches.
